Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
05/2012
05/09/2012EP1379337B1 Generation of pharmaceutical agent particles using focused acoustic energy
05/09/2012EP1372610B1 Powder inhaler formulations
05/09/2012EP1323440B1 Peritoneal dialysates
05/09/2012CN1975420B Producing method of functional quantum point used for specific recognizating tumor cell
05/09/2012CN1636577B Vaginal care composition
05/09/2012CN102448498A A therapeutic combination comprising a pulmonary surfactant and a steroid
05/09/2012CN102448497A Continuous administration of integrin ligands for treating cancer
05/09/2012CN102448496A Medicine composition having iodine and steroid and application to treatment of rhinitis
05/09/2012CN102448495A Novel pharmaceutical composition for prevention and/or treatment of attention deficit/hyperactivity disorder
05/09/2012CN102448454A Therapeutic combination comprising a plk1 inhibitor and an antineoplastic agent
05/09/2012CN102448450A Compositions comprising trans-tert-butyl cyclohexanol as skin irritation-reducing agent
05/09/2012CN102441179A Silicon dioxide base ultrasonic contrast medium/high intensity focused ultrasound (HIFU) synergist and preparation method thereof
05/09/2012CN102441171A Local temperature-sensitive antibacterial drug sustained-release agent and preparation method thereof
05/09/2012CN102441170A Methods for administering DPD inhibitors in combination with 5-FU and 5-FU prodrugs
05/09/2012CN102441169A Antibiotic compound containing beta-lactam antibiotics and ionic chelating agents
05/09/2012CN102441168A Medicine composition containing apigenin, apigenin derivant and Bc1-2 inhibitor and application thereof in preparation of medicines capable of treating cancer
05/09/2012CN102441167A Pharmaceutical composition having apiolin and apiolin derivant as well as histone deaceylase inhibitors and application thereof
05/09/2012CN102441157A Use of bombesin/gastrin-releasing peptide antagonists for the treatment of inflammatory conditions, acute lung injury and bipolar disorder
05/09/2012CN102440961A Targeting polymer micelle containing acid-sensitive subsurface, and preparation method thereof
05/09/2012CN101856498B Anti-septic shock medicine composition and application thereof
05/09/2012CN101380309B Metered dose inhalation aerosol and preparation method thereof
05/08/2012US8173778 Antibody to a guanine nucleotide exchange factor
05/08/2012US8173709 Anti-infective methods for treating pathogen-induced disordered tissues
05/08/2012US8173707 Ophthalmologic irrigation solutions and method
05/08/2012US8173615 TRPM-2 antisense therapy
05/08/2012US8173602 Detecting CYP24 expression level as a marker for predisposition to cancer
05/08/2012US8173595 Methods and compositions for the inhibition of thrombus formation
05/08/2012US8173592 Method for a programmed controlled ovarian stimulation protocol
05/08/2012US8173424 Internalizing ErbB2 antibodies
05/08/2012US8173177 Compositions of botanical extracts for cancer therapy
05/08/2012US8173140 Compositions and methods for activating innate and allergic immunity
05/08/2012US8173129 Methods and compositions for treating autoimmune diseases
05/08/2012US8173123 Methods of treating colitis involving IL-13 and NK-T cells
05/08/2012US8173107 Delivery of antipsychotics through an inhalation route
05/08/2012CA2623339C Virulence genes in the vgc2 cluster of salmonella
05/08/2012CA2467449C Lactic acid bacteria and their use for treating and preventing cancer
05/08/2012CA2458386C L-methionine as a stabilizer for nesp/epo in hsa-free formulations
05/08/2012CA2383724C Drug delivery system using membrane mimetics
05/08/2012CA2377661C Use of fatty acid derivative for the treatment of external secretion disorders
05/08/2012CA2368184C Method and means for treating post-polio syndrome
05/08/2012CA2362264C Cytokine-binding domain
05/08/2012CA2284271C A preventive or therapeutic agent for sensitized t cell-mediated diseases comprising il-6 antagonist as an active ingredient
05/08/2012CA2163211C Inhibition of migration inhibitory factor in the treatment of diseases involving cytokine-mediated toxicity
05/03/2012WO2012057343A1 Nad(p)h oxidase inhibitor, therapeutic agent for oxidative stress-related diseases, therapeutic method for oxidative stress-related diseases, and screening method
05/03/2012WO2012057294A1 Method for treating malaria, method for killing malaria parasite, and use of the methods
05/03/2012WO2012056246A1 Combination treatment of major depressive disorder
05/03/2012WO2012055057A1 Therapeutic use of dimiracetam to prevent the hand & foot syndrome caused by sorafenib
05/03/2012WO2010146348A9 Crystalline form of pemirolast
05/03/2012US20120109106 Drug delivery system for accelerated subcutaneous absorption
05/03/2012US20120108634 Farnesyl protein transferase inhibitor combinations with antiestrogen agents
05/03/2012US20120108603 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase
05/03/2012US20120108570 Pharmacological Treatment for Sleep Apnea
05/03/2012US20120108520 Antimicrobial Compounds and Formulations
05/03/2012US20120107833 Antibody specific for a mammalian sphingosine kinase type 2 isoform protein and methods of use thereof
05/03/2012US20120107827 PSMCs As Modifiers of the RB Pathway and Methods of Use
05/03/2012US20120107417 Effective Antitumor Treatments
05/03/2012US20120107394 Immuno-compatible hydrogel system
05/03/2012US20120107371 Stimuli-responsive systems for controlled drug delivery
05/03/2012US20120107288 Compositions and methods for inhibiting pathogenic growth
05/03/2012CA2828238A1 Therapeutic use of dimiracetam to prevent the hand & foot syndrome caused by sorafenib
05/03/2012CA2819230A1 Methods and compositions for assessing and treating cancer
05/02/2012EP2447258A1 Dioxanes derived from regrouping carbohydrates and c-glycosides, method for obtaining same, and uses thereof
05/02/2012EP2446903A2 Methods, compositions, and kits for treating pain and pruritis
05/02/2012EP2446884A1 Composition for inhibiting inflammation comprising hyaluronic acid and a hmg-coa reductase inhibitor
05/02/2012EP2445534A2 Continuous administration of cilengitide in cancer treatments
05/02/2012EP2445533A1 Method for treating or ameliorating mucocutaneous or ocular toxicities
05/02/2012EP2445510A1 Compositions for treating degenerative joint diseases
05/02/2012EP2445506A1 The use of spinosyns and spinosyn compositions against diseases caused by protozoans, viral infections and cancer
05/02/2012EP2445500A1 Combination treatment op a g2 checkpoint inhibitor (sb-218078) and a chemotherapeutic agent for tumorigenic cells in solid tumors
05/02/2012EP2445491A1 Pharmaceutical composition for emergency contraception
05/02/2012EP2445338A1 Synergistic combination to enhance blood glucose and insulin metabolism
05/02/2012EP1992361B1 Remedy or preventive for digestive ulcer
05/02/2012EP1945224B1 Reduction of side effects from aromatase inhibitors used for treating breast cancer
05/02/2012EP1702064B1 A biomimetic composition reinforced by a polyelectrolytic complex of hyaluronic acid and chitosan
05/02/2012EP1487431B1 Preventing and/or treating cardiovascular disease and/or associated heart failure
05/02/2012EP1429723B1 Treating effects of excessive reactive oxygen species
05/02/2012EP1418893B1 Compositions and techniques for localized therapy of restenosis
05/02/2012EP1389130B1 Use of osteopontin for the treatment and/or prevention of neurologic diseases
05/02/2012EP1343822B1 Means for the diagnosis and therapy of ctcl
05/02/2012EP1256348B1 Remedies for hepatitis c
05/02/2012EP1032403B1 Nutritional supplement for cerebral metabolic insufficiencies
05/02/2012CN1835759B Micronutrient supplement
05/02/2012CN102439153A Compositions for stimulation of mammalian innate immune resistance to pathogens
05/02/2012CN102439007A Amide derivative
05/02/2012CN102438614A Pyrone analogs for therapeutic treatment
05/02/2012CN102438603A Prevention and treatment of sarcopenia
05/02/2012CN102438588A Methods of treatment using combination therapy
05/02/2012CN102430119A Construction method of drug evaluation model for dermal pathology of tuberculosis rabbit
05/02/2012CN102429908A Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases
05/02/2012CN102429889A Large ring lactone type medicament capsule and preparation method thereof
05/02/2012CN101808636B Treatment of melanoma
05/01/2012US8168643 Reversible inhibitors of S-adenosyl-L-homocysteine hydrolase and uses thereof
05/01/2012US8168637 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment of diabetes
05/01/2012US8168629 Analgesic combination of tramadol and meloxicam
05/01/2012US8168619 Hormonal composition based on a progestational agent and an oestrogen and use thereof
05/01/2012US8168616 Combination comprising a renin inhibitor and an angiotensin receptor inhibitor for hypertension
05/01/2012US8168232 Formulations and methods of using nitric oxide mimetics in cancer treatment
05/01/2012US8168223 Engineered particles and methods of use
05/01/2012US8168182 Method for treating erectile dysfunction
05/01/2012US8168168 Infectivity-enhanced conditionally-replicative adenovirus and uses thereof
1 ... 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 ... 1151